Collaboration Details
Krsnaa Diagnostics Limited has entered into a collaboration with AZmed, a global medical imaging company specializing in artificial intelligence solutions for radiology. The collaboration will evaluate AZmed's AZtrauma solution, which is part of its Rayvolve AI suite, specifically for the detection and triage of fractures, joint effusions, and dislocations on X-rays.
Strategic Rationale
The collaboration represents a strategic step in Krsnaa's plan to leverage advanced AI technologies to strengthen radiology operations, enhance reporting efficiency, and build capacity for future growth. The company processes more than 5 million X-rays annually through one of India's largest X-ray reporting operations.
Operational Scale and Network
Krsnaa Diagnostics delivers diagnostic imaging, pathology and teleradiology services across 19 states and union territories through:
- 190+ CT and MRI centres
- 2,000+ X-ray centres
- 212 pathology laboratories
- More than 4,700 patient collection centres
The company operates World's first American College of Radiology (ACR)-recognised Teleradiology HUB outside US Borders in Pune, Maharashtra, which provides round-the-clock reporting services.
Potential Benefits
The collaboration aims to explore integration of globally developed AI capabilities into Krsnaa's diagnostic network, with potential benefits including:
- Improved operational productivity
- Greater utilization of radiologist capacity
- Enhanced scalability as diagnostic volumes grow
- Additional headroom to support business expansion
- Potential operating leverage unlock
Conditions and Limitations
The realization of benefits is subject to successful evaluation, regulatory approvals, and implementation. The press release contains forward-looking statements that are subject to risks and uncertainties including outcome of evaluation, receipt of regulatory approvals, contractual and data-related requirements, technological performance, and market conditions.
Leadership Commentary
Mr. Yash Mutha, Managing Director, stated: "Healthcare AI presents a significant opportunity to transform the future of diagnostic services. By integrating advanced AI technologies into our high-volume radiology operations, we aim to unlock operating leverage, enhance productivity, expand reporting capacity and build a more scalable operating model."
Dr. Madhuri Ghate, Vice President - Radiology, added: "With approximately 5 million X-rays reported every year, Krsnaa has the scale and operational experience to evaluate how AI-assisted radiology can contribute to more efficient workflows while maintaining the central role of our radiologists in clinical decision-making."
Julien Vidal, CEO of AZmed, commented: "India represents a significant opportunity for the advancement of AI-enabled radiology. Krsnaa Diagnostics' extensive reach and reporting capabilities make it a valuable partner for bringing our leading AI solutions for medical imaging into high-volume diagnostic workflows."
About AZmed
AZmed is a European MedTech company founded in Paris in 2018. Their Rayvolve solution became the first AI software to receive CE marking for fracture detection on X-rays in 2019, and the company has secured multiple 510(k) clearances from the US Food and Drug Administration (FDA). Their technology has analyzed more than 15 million medical images globally and is used by more than 2,500 healthcare facilities worldwide.